Article Details

China to remain a headwind in 2025 for J&J MedTech, CFO says - Medical Device Network

Retrieved on: 2025-01-22 17:47:55

Tags for this article:

Click the tags to see associated articles and topics

China to remain a headwind in 2025 for J&J MedTech, CFO says - Medical Device Network. View article details on hiswai:

Excerpt

J&J MedTech has reported a 4.8% growth in 2024's global sales, though it expects its 2025 outlook to remain affected by weak demand in China.

Article found on: www.medicaldevice-network.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up